Home/Filings/4/0000950170-23-073629
4//SEC Filing

Prout Samantha 4

Accession 0000950170-23-073629

CIK 0001178879other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 5:09 PM ET

Size

5.3 KB

Accession

0000950170-23-073629

Insider Transaction Report

Form 4
Period: 2023-12-26
Prout Samantha
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2023-12-26$14.00/sh7,659$107,228121,912 total
Footnotes (1)
  • [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.005 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001743122

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:09 PM ET
Size
5.3 KB